/

ORMP

Oramed Pharmaceuticals Inc.Closed

4.14−0.03 −0.72%USD

NasdaqCM · as of Oct 14, 16:00 ET · 15m delayAfter hours 4.14 0.00%

Open

4.12

Prev close

4.17

Day range

4.124.22

52-week range

2.095.47

Volume

146.55K0.78×

Mkt cap

172.21M

P/E ttm

1.00

Fwd P/E

-51.75

EPS ttm

4.13

Div yield

6.00%

Earnings

Aug 10, 2026

From 52w high

−24.31%

Price Chart

Yahoo Finance · delayed

ORMPOct 14, 2026O 4.12H 4.22L 4.12C 4.14−0.03 (−0.72%)Vol 146.60K

SMA 504.65
SMA 2003.97

1Y change +71.78% since Oct 13, 2025 close539 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

ORMP Oramed Pharmaceuticals Inc. · Last Guard Finance

SEAS

Seasonality · ORMP

2007–2026 · monthly returns

Strongest month Nov +8.89%Weakest month Oct −6.77%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	18.2	1.5	-0.6	14.1	2.3	21.2	-15.4	23.3	-7.0	-11.3			+45.3%
2025	-7.4	-6.7	2.4	8.4	0.9	-3.8	-4.4	2.3	20.0	-9.5	19.2	0.0	+17.8%
2024	29.9	9.7	-11.2	-20.5	-6.0	17.9	-0.8	-6.3	2.1	-2.5	-0.4	2.1	+4.8%
2023	-83.5	5.5	3.8	4.1	78.0	-11.4	-5.3	-3.2	-20.4	-29.9	21.3	4.1	−80.8%
2022	-37.3	15.0	-16.0	-40.6	-9.9	-1.1	91.7	-2.5	-24.3	9.7	18.8	42.4	−15.8%
2021	71.2	22.7	14.0	4.9	8.1	16.1	6.1	38.7	11.7	6.5	-17.9	-25.7	+236.8%
2020	1.6	-22.0	-25.5	1.6	1.6	12.4	4.0	-4.9	-25.2	-3.1	68.4	-0.5	−17.7%
2019	5.0	1.6	13.8	0.8	-18.3	19.7	1.9	-9.3	-3.9	-0.3	38.7	16.8	+71.7%
2018	-9.6	-10.9	-10.2	3.7	17.2	-6.1	-28.1	-7.3	-1.6	-13.3	-3.3	-26.5	−66.7%
2017	7.0	-7.6	1.7	26.0	5.2	-4.7	3.9	7.2	14.8	-0.1	-7.9	-1.5	+47.1%
2016	-25.1	10.8	-6.1	30.2	0.6	-4.4	-2.0	-11.8	0.7	-8.5	-7.5	-0.3	−28.4%
2015	10.5	-10.3	40.9	13.2	-7.6	-14.7	16.0	-14.7	-2.7	20.7	37.9	-6.0	+87.5%
2014	43.2	-32.7	-20.6	-18.1	-13.8	15.5	-13.4	21.7	-19.8	-11.7	-16.4	-24.0	−70.4%
2013	86.6	21.8	-4.4	8.7	-1.8	-11.0	-11.5	0.8	-14.8	4.7	27.7	85.9	+289.6%
2012	7.1	-6.7	-3.6	18.5	6.3	-11.8	13.3	-5.9	0.0	-3.1	0.0	6.5	+17.9%
2011	10.0	-6.1	-12.9	18.5	3.1	-12.1	0.0	0.0	20.7	-5.7	-9.1	-6.7	−6.7%
2010	-11.1	2.5	17.1	4.2	0.0	-4.0	-12.5	-7.1	7.7	-16.7	-11.4	-3.2	−33.3%
2009	-10.3	-28.6	32.0	-3.0	34.4	11.6	4.2	-8.0	19.6	-12.7	-10.4	4.7	+15.4%
2008	26.9	75.8	-13.8	12.0	12.5	1.6	20.3	-6.5	-13.9	-24.2	6.4	-22.0	+50.0%
2007						-34.8	-7.0	10.0	-13.6	-28.9	14.8	-16.1	−60.6%

INSD

Insider Activity · ORMP

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

50K shares

Sells, 6 months

210.4K shares

Net shares

−160.4K

Net change in insider shares

−1.80%

Date	Insider	Transaction	Shares	Value
Jul 1, 2026	Hexter JoshuaChief Operating Officer	Conversion of Exercise of derivative security at price 3.69 per share.	50K	$184.50K
Jun 30, 2026	Hexter JoshuaChief Operating Officer	Sale at price 4.46 per share.	137K	$611.43K
Jun 30, 2026	Gabay AvrahamChief Financial Officer	Sale at price 4.51 per share.	73.4K	$330.74K
Mar 16, 2026	Hexter JoshuaChairman of the Board	Stock Award(Grant) at price 0.00 per share.	95.9K	—
Mar 16, 2026	Gabay AvrahamChief Financial Officer	Stock Award(Grant) at price 0.00 per share.	95.9K	—
Mar 16, 2026	Kidron NadavChief Executive Officer	Stock Award(Grant) at price 0.00 per share.	167K	—
Mar 16, 2026	Kidron MiriamOfficer and Director	Stock Award(Grant) at price 0.00 per share.	119.6K	—
Mar 11, 2026	Kidron NadavChief Executive Officer	Stock Gift at price 0.00 per share.	100K	—
Jan 21, 2026	Kidron NadavChief Executive Officer	—	109K	—
Jan 21, 2026	Kidron MiriamOfficer and Director	—	19K	—
Jan 21, 2026	Hexter JoshuaChief Operating Officer	—	19K	—
Jan 21, 2026	Gabay AvrahamChief Financial Officer	—	19K	—
Jan 13, 2026	Kidron MiriamOfficer and Director	Stock Gift at price 0.00 per share.	86.2K	—
Dec 30, 2025	Hexter JoshuaChief Operating Officer	Stock Award(Grant) at price 0.00 per share.	212.3K	—
Dec 30, 2025	Gabay AvrahamChief Financial Officer	Stock Award(Grant) at price 0.00 per share.	196.2K	—
Dec 30, 2025	Mayer Arie Ph.D.Director	Stock Award(Grant) at price 0.00 per share.	34.9K	—
Dec 30, 2025	Shapiro BenjaminDirector	Stock Award(Grant) at price 0.00 per share.	33.5K	—
Dec 30, 2025	Aghion DanielDirector	Stock Award(Grant) at price 0.00 per share.	36.3K	—
Dec 30, 2025	Reznick YehudaDirector	Stock Award(Grant) at price 0.00 per share.	36.3K	—
Dec 30, 2025	Kidron NadavChief Executive Officer	Stock Award(Grant) at price 0.00 per share.	559.6K	—

CONG

Congress Trades · ORMP

House and Senate reports since 2025

Members

0 last bought

Buys

~$0

Sells

~$32.5K

Net

−$32.5K

est. bought − sold

Latest

Jan 10, 25

Brad Knott

Members who traded it

Member	Buys	Sells	Est. net	Last move
Brad Knott NC13		1	−$32.5K	Sold Jan 10, 25

Bought and sold by quarter (est.)

Members of Congress's ORMP trades, newest first
Traded	Member	Owner	Type	Amount	Filed	Report
Jan 10, 25	Brad Knott NC13	Self	Sell	$15,001 - $50,000	Feb 25, 25 (46d)	PDF

From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades

13F

Investors Holding ORMP

latest 13F filings of 29 followed managers

Investors holding ORMP
Investor	Value	Of portfolio	Shares	Change	Quarter
Renaissance Technologies	$884.1K	0.00%	183.80K	+24%	Q2 2026

From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors

ORMP

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

ORMP

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About Oramed Pharmaceuticals Inc.

Seasonality · ORMP

Insider Activity · ORMP

Congress Trades · ORMP

Members who traded it

Bought and sold by quarter (est.)

Investors Holding ORMP

Investors Holding ORMP

Congress Trades · ORMP

Members who traded it

Bought and sold by quarter (est.)

Insider Activity · ORMP

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About Oramed Pharmaceuticals Inc.

Earnings & Dividends

News

Seasonality · ORMP